Literature DB >> 8558294

Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects.

K E Hill1, Y Xia, B Akesson, M E Boeglin, R F Burk.   

Abstract

Selenoprotein P, a selenium-rich plasma protein, is an index of selenium status in rats. Antibodies against human selenoprotein P were raised to study the protein and to develop a radioimmunoassay for it. A single collection of plasma from a healthy person in the United States contained 1.84 mumol selenium/L and was defined as containing 1 Unit (U) selenoprotein P/L. Removal of selenoprotein P from the reference plasma by an antibody column indicated that 0.81 mumol selenium/L, or 44% of the plasma selenium, was present as selenoprotein P. Work by others had determined that glutathione peroxidase accounted for 12% of plasma selenium. Stored plasma samples from selenium-deficient (Dechang County) and selenium-supplemented (Mianning County) populations in China were assayed for selenoprotein P. Boys aged 8-12 y had selenoprotein P concentrations of 0.10 +/- 0.04 U/L (n = 22) in Dechang and 0.39 +/- 0.17 U/L (n = 17) in Mianning. Supplementation with 100 micrograms selenium as selenate per day for 14 d raised those levels to 0.51 +/- 0.13 U/L in Dechang and to 0.76 +/- 0.27 U/L in Mianning. Similar results were obtained in men, and plasma selenium concentrations correlated with selenoprotein P concentrations. A study comparing indices of selenium status was conducted in the two counties. Selenoprotein P concentration in Dechang subjects (n = 79) was 36% of that in Mianning subjects (n = 117). For plasma glutathione peroxidase activity the value was 54%; for plasma selenium, 47%; and for whole blood selenium, 64%. We conclude that selenoprotein P is the major selenoprotein in human plasma and that its concentration is an index of selenium nutritional status that appears to be as sensitive as other indices in common use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558294     DOI: 10.1093/jn/126.1.138

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  36 in total

1.  Serum selenium and risk of prostate cancer-a nested case-control study.

Authors:  Ulrike Peters; Charles B Foster; Nilanjan Chatterjee; Arthur Schatzkin; Douglas Reding; Gerald L Andriole; E David Crawford; Stefan Sturup; Stephen J Chanock; Richard B Hayes
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

2.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Plasma and breast-milk selenium in HIV-infected Malawian mothers are positively associated with infant selenium status but are not associated with maternal supplementation: results of the Breastfeeding, Antiretrovirals, and Nutrition study.

Authors:  Valerie L Flax; Margaret E Bentley; Gerald F Combs; Charles S Chasela; Dumbani Kayira; Gerald Tegha; Debbie Kamwendo; Eric J Daza; Ali Fokar; Athena P Kourtis; Denise J Jamieson; Charles M van der Horst; Linda S Adair
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

4.  Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial.

Authors:  Raymond F Burk; Kristina E Hill; Amy K Motley; Daniel W Byrne; Brooke K Norsworthy
Journal:  Am J Clin Nutr       Date:  2015-10-14       Impact factor: 7.045

5.  Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects.

Authors:  Yiming Xia; Kristina E Hill; Ping Li; Jiayuan Xu; Dingyou Zhou; Amy K Motley; Li Wang; Daniel W Byrne; Raymond F Burk
Journal:  Am J Clin Nutr       Date:  2010-06-23       Impact factor: 7.045

6.  Bioinformatics of Selenoproteins.

Authors:  Didac Santesmasses; Marco Mariotti; Vadim N Gladyshev
Journal:  Antioxid Redox Signal       Date:  2020-04-23       Impact factor: 8.401

Review 7.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

Review 8.  Selenium and the prevention of prostate and colorectal cancer.

Authors:  Ulrike Peters; Yumie Takata
Journal:  Mol Nutr Food Res       Date:  2008-11       Impact factor: 5.914

9.  Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults.

Authors:  Gerald F Combs; Douglas N Midthune; Kristine Y Patterson; Wesley K Canfield; A David Hill; Orville A Levander; Philip R Taylor; James E Moler; Blossom H Patterson
Journal:  Am J Clin Nutr       Date:  2009-04-29       Impact factor: 7.045

10.  Serum selenium and serum lipids in US adults.

Authors:  Joachim Bleys; Ana Navas-Acien; Saverio Stranges; Andy Menke; Edgar R Miller; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.